Merck Invests More than € 300 Million in New Life Science Production Site in Korea

Contributed by: Business Wire

Images

Rendering of Merck's new Bioprocessing Production Center in Daejeon, South Korea
Rendering of Merck's new Bioprocessing Production Center in Daejeon, South Korea
Business Wire embedded0

Tags

Chemicals/Plastics
Health
Manufacturing
Health Technology
Pharmaceutical
Biotechnology
Merck

More Like This

Architect's rendering of Merck Life Science's new quality control building now under construction. (Photo: Business Wire)

Merck Invests € 62 Million in New Quality Control Facility in Darmstadt, Germany

Merck opens newly expanded Life Science distributed center, with added downfilling capabilities in Schnelldorf, Germany. (Photo: Business Wire)

Merck Completes € 180 Million Investment to Expand Schnelldorf Distribution Center

Business Wire logo

SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production

Merck invests €70 million to triple its antibody-drug conjugate (ADC) manufacturing capacity and upgrade 3200 m2 at its BioConjugation Center of Excellence in St. Louis, Missouri, USA. (Photo: Business Wire)

Merck Invests €70 Million to Expand ADC Manufacturing for Novel Cancer Therapies

Merck's new €290 million biosafety testing facility in Rockville, Maryland, USA features advanced testing capabilities. (Photo: Business Wire)

Merck Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA

PR Newswire associated0

LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World

Chiesi Group's new Biotech Center of Excellence brings the future of medicine to Parma